Abstract:Diarrheal acquired immune deficiency syndrome (AIDS) seriously affects the quality of life of patients. In this study, we analyzed the differences in the intestinal microbiota among healthy individuals, AIDS patients without diarrhea and AIDS patients with diarrhea through high-throughput sequencing. The microbial diversity in the intestines of patients in the AIDS diarrhea group was significantly increased, and after treatment with Xielikang, the intestinal microbial diversity returned to the baseline level. At the phylum level, compared those in to the healthy (ZC) and AIDS non diarrhea (FN) groups, the relative abundances of Bacteroidetes and Verrucomirobia in the AIDS diarrhea (FA) group before treatment were significantly increased, while the relative abundance of Firmicutes was significantly decreased. Similarly, compared with those in the FA group, the relative abundances of Bacteroidea and Firmicutes in the AIDS diarrhea (FB) group after treatment were significantly increased, while the relative abundance of Firmicutes was significantly decreased after treatment. Additionally, there was no significant difference between the ZC and FN groups. At the genus level, compared with those in the ZC group, the relative abundance of Prevotella and Escherichia_Shigella in the FA group was significantly increased, while the relative abundances of Megamonas and Bifidobacterium was significantly decreased compared to that in the ZC group. After treatment with Xielikang, the relative abundance of Prevotella and Escherichia_Shigella in the FB group were significantly decreased, while the relative abundances of Megamonas and Bifidobacteria were significantly increased than those in the FA group; moreover, there was no significant difference between the ZC and FN groups. The functional prediction results showed that the ketodeoxyoctonate (Kdo) transfer to lipid IVA III and the superpathway of N-acetylglucosamine pathways in the AIDS diarrhea group were significantly altered. The correlation analysis results showed that Dorea was positively correlated with inflammatory factors, while Streptococcus and Lactobacillus were negatively correlated with inflammatory factors. The composition and function of the intestinal microbiota changed significantly in AIDS diarrhea patients, which affected the immune function of the host. The Xielikang capsule modulated the composition of the intestinal microbiota in AIDS diarrhea patients and thus improved immune function and reduced diarrheal symptoms.

Enterobacteria and Fungal Infection in AIDS Patients with Chronic Diarrhea

Clinical Research of Fungal Infection in 296 AIDS Patients

Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: an Observational Study in A Chinese Population

HIV-infected patients with chronic diarrhea stool specimens Detection of pathogenic microorganisms

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Analysis of 91 cases of diarrhea in patients with HIV/AIDS

Characterization of intestinal fungal community diversity in people living with HIV/AIDS (PLWHA)

Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital.

Traditional Chinese medicine (Xielikang) reduces diarrhea symptoms in acquired immune deficiency syndrome (AIDS) patients by regulating the intestinal microbiota

Pathogenic Bacteria Distribution and Drug Resistance Analysis in HIV/AIDS Patients with Lower Respiratory Tract Infection in Yunnan Province

Pathogenic Microorganism Detection in AIDS Patients Using Bronchoalveolar Lavage Fluid.

Changes in peripheral blood inflammatory factors (TNF-α and IL-6) and intestinal flora in AIDS and HIV-positive individuals

Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4+ T cell reduction and immune activation

Clinical Analysis of 35 Cases of AIDS with Invasive Fungal Infection

Fecal Bacterial Microbiome Diversity In Chronic Hiv-Infected Patients In China

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

Gastrointestinal Talaromyces marneffei infection in a patient with AIDS: A case report and systematic review

Effect of Nutritional Support on Immunity Function in the Acquired Immune Deficiency Syndrome Patients

Molecular Characterization of Stool Microbiota in HIV-infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rdna) Quantification and Correlations with Immune Activation.

Unusual disseminated Talaromyces marneffei infection presenting with fever and diarrhea in an AIDS patient: a case report and literature review

Characterization of the Intestinal Fungal Microbiome in HIV and HCV Mono-Infected or Co-Infected Patients